Merck (MRK) Long-Term Investments (2009 - 2026)

Merck (MRK) has reported Long-Term Investments for 18 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Long-Term Investments rose 57.88% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 57.88% increase from a year earlier, with the FY2025 full-year figure at $956.0 million, up 106.48% from the prior year.
• Long-Term Investments was $1.2 billion for Q2 2026 at Merck, up from $1.1 billion in the prior quarter.
• Over five years, Long-Term Investments peaked at $1.3 billion in Q3 2023 and troughed at $238.0 million in Q2 2022.
• A 5-year average of $782.2 million and a median of $865.0 million in 2025 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments soared 410.08% in 2023 and sank 78.29% in 2024, its largest moves.
• Over 5 years, Long-Term Investments stood at $1.0 billion in 2022, then slumped by 75.17% to $252.0 million in 2023, then soared by 83.73% to $463.0 million in 2024, then surged by 106.48% to $956.0 million in 2025, then grew by 27.82% to $1.2 billion in 2026.
• The last three Long-Term Investments figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $956.0 million (Q4 2025), per Business Quant data.